| Hodgkin's Disease |
18.2% |
| B-cell Lymphoma |
14.1% |
| Product Used For Unknown Indication |
11.2% |
| Non-hodgkin's Lymphoma |
10.2% |
| Chronic Lymphocytic Leukaemia |
10.1% |
| Breast Cancer |
10.1% |
| Drug Use For Unknown Indication |
5.0% |
| Nodular (Follicular) Lymphoma |
3.4% |
| Prophylaxis |
3.2% |
| Diffuse Large B-cell Lymphoma |
2.8% |
| Premedication |
1.7% |
| Human Immunodeficiency Virus Type I Infection With Secondary Cancers |
1.5% |
| Lymphoma |
1.4% |
| Malignant Breast Neoplasm |
1.3% |
| Hypertension |
1.1% |
| Acute Leukaemia |
1.0% |
| Her-2 Positive Breast Cancer |
1.0% |
| Peripheral T-cell Lymphoma Unspecified |
1.0% |
| Constipation |
0.9% |
| Foetal Exposure Timing Unspecified |
0.8% |
